Hostname: page-component-745bb68f8f-lrblm Total loading time: 0 Render date: 2025-01-15T00:26:57.672Z Has data issue: false hasContentIssue false
  • English
  • Français

Motor, Behavioral and Pharmacologic Findings in Tourette's Syndrome

Published online by Cambridge University Press:  05 January 2016

Joseph Jankovic  and
Haydee Rohaidy
Joseph Jankovic*
Affiliation:
Department of Neurology, Baylor College of Medicine, Houston, Texas
Haydee Rohaidy
Affiliation:
Department of Neurology, Baylor College of Medicine, Houston, Texas
*
Department of Neurology, Baylor College of Medicine, 1 Baylor Plaz, Houston, Texas 77030 U.S.A.
Rights & Permissions [Opens in a new window]

Abstract:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

We studied 112 patients with Tourette's syndrome (TS); the male-to-female ratio was 3.8, the mean age of onset was 7.3 years, and the average duration of symptoms prior to the initial evaluation was 15.2 years. Seventy-nine percent of the patients had at least one family member with motor or vocal tics, and an additional 10 percent had a family member with marked obsessive-compulsive behavior. Simple motor tics occurred as the presenting symptom in about one-third of patients; one-third had multiple motor tics at the onset, and another third started with vocal tics. During the course of the illness all patients developed multifocal motor tics and 86 percent had vocal tics. Verbal and mental coprolalia was present in 44 percent of the patients. Copropraxia was seen in 19 percent of patients, and both coprolalia and copropraxia were more frequent among the males than expected. Attentional deficit disorder was diagnosed in 36 percent of the patients and 32 percent had obsessive-compulsive personality. Sleep disturbances were reported by 62 percent of the patients and polysomnography in 34 patients showed motor and vocal tics during all stages of sleep, sleep apnea, abnormal arousal pattern, and other sleep disturbances. Patients with mild symptoms improved with clonidine or clonazepam, but those with more advanced disorder required fluphenazine, pimozide, haloperidol or tetrabenazine.

Type
Research Article
Information
Canadian Journal of Neurological Sciences , Volume 14 , Issue S3 , August 1987 , pp. 541 - 546
Copyright
Copyright © Canadian Neurological Sciences Federation 1987

References

REFERENCES

1.Gilles de la Touretle, G.Etude sur une affection nerveuse caractérisée par de l’incoordination motrice accompagnée d’écholalie et de coprolalie. Archives de Neurologie 1985: 9: 19–24, 153–156.Google Scholar
2.Moldofsky, H.Tullis, C.Lamon, R.Multiple tic syndrome (Gilles de la Tourette’s syndrome). J Nerv Ment Dis 1974: 159: 282–291.CrossRefGoogle Scholar
3.Shapiro, AK.Shapiro, ES.Bruun, RD.Sweet, RD.Gilles de la Tourette syndrome. New York. Raven Press 1978. pp 119–149.Google Scholar
4.Nee, LE, Caine, ED.Polinsky, RJ, et al. Gilles de la Tourette syndrome: Clinical and family study of 50 cases. Ann Neurol 1980:7: 41–49.CrossRefGoogle ScholarPubMed
5.Lees, AJ.Robertson, M, Trimble, MR, Murray, NMF.A clinical study of Gilles de la Tourette syndrome in the United Kingdom. J Neurol. Neurosurg Psychiatry 1984; 47: 1–8.CrossRefGoogle ScholarPubMed
6.Erenberg, G.Cruse, RP.Rothner, AD.Tourette syndrome: an analy-sis of 200 pediatric and adolescent cases. Cleve Clin Q 1986; 53: 127–131.CrossRefGoogle Scholar
7.Jankovic, J, Fahn, S.The phenomenology of tics. Movement Disor-ders 1986: 1: 17–26.CrossRefGoogle ScholarPubMed
8.Shapiro, AK, Shapiro, E.Tourette syndrome. History and present state. In: Friedhoff, AJ.Chase, TN (eds) Gilles de la Tourette Syndrome. Adv Neurol. Raven Press, New York. 1982: Vol 35, pp 17–23.Google Scholar
9.Obeso, JA.Rothwell, JC.Marsden, CD.Simple tics in Gilles de la Tourette’s syndrome are not prefaced by a normal premovement EEG potential. J Neurol Neurosurg Psychiatry 1981;44:735–738.CrossRefGoogle Scholar
10.Bliss, J.Sensory experiences of Gilles de la Tourette’s syndrome. Arch Gen Psychiatry 1980: 37: 1343–1347.CrossRefGoogle Scholar
11.Bullen, JG, Hemsley, DR.Sensory experience as a trigger in Gilles de la Tourette’s syndrome. J Behav Ther Exp Psychiatry 1983; 14: 197–201.CrossRefGoogle ScholarPubMed
12.Jankovic, J.Clinical features, differential diagnosis and pathogene-sis of blepharospasm and cranial-cervical dystonia. In: Bosniak, SL (ed) Blepharospam. New York, 1985. pp 67–82.Google Scholar
13.Frankel, M, Cummings, JL.Neuro-opthalmic abnormalities in Tourette’s syndrome: Functional and anatomic implications. Neurology 1984:34: 359–361.CrossRefGoogle Scholar
14.Glaze, DG, Frost, JD, Jankovic, J.Gilles de la Tourette’s syndrome. Disorder of arousal. Neurology 1983; 33: 586–592.CrossRefGoogle ScholarPubMed
15.Kovacevic-Ristanovic, R, Goetz, CG, Tanner, CM.Gilley, D.Gilles de laTourette’s syndrome and sleep. Neurology 1987 (in press).Google Scholar
16.Jankovic, J.The neurology of tics. In: Fahn, S, Marsden, CD, eds. Movement Disorders 2, Butterworth Scientific 1987; 383–405.Google Scholar
17.Frankel, M.Cummings, JL.Robertson, MM.et al. Obsessions and compulsions in Gilles de la Tourette’s syndrome. Neurology 1986; 36: 378–382.CrossRefGoogle ScholarPubMed
18.Pauls, DL, Towbin, KE.Leckman, JF.et al. Gilles de la Tourette’s syndrome and obsessive-compulsive disorder. Evidence supporting a genetic relationship. Arch Gen Psychiatry 1986; 43: 1180–1182.CrossRefGoogle ScholarPubMed
19.Pauls, DL.Hurst, CR.Kruger, SD.et al. Gilles de la Tourette’s syndrome and attention deficit disorder with hyperactivity. Evidence against a genetic relationship. Arch Gen Psychiatry 1986: 43: 1177–1179.CrossRefGoogle ScholarPubMed
20.Nuwer, MR.Coprolalia as an organic symptom. In: Gilles de la Tourette syndrome, Friedhoff, AJ, Chase, TN, eds. Adv Neurol, Raven Press, New York 1982; 35: 363–368.Google Scholar
21.Lees, AJ.Tolosa, Tics E..In: Jankovic, J, Tolosa, E. eds. Parkinson’s disease and movement disorders, Urban and Schwarzenberger Baltimore, Maryland. 1987. in press.Google Scholar
22.Pollack, MA.Cohen, NL.Friedhoff, AJ.Gilles de la Tourette syndrome: Familial occurrence and precipitation by methylphenidate therapy. Arch Neurol 1977: 34: 630–632.CrossRefGoogle ScholarPubMed
23.Kurlan, R, Behr, J, Medved, L.et al. Familial Tourette syndrome: Report of a large pedigree and potential for linkage analysis. Neurology 1986; 36: 772–776.CrossRefGoogle ScholarPubMed
24.Pauls, DL.Leckman, JF.The inheritance of Gilles de la Tourette’s syndrome and associated behaviors. Evidence for autosomal dominant transmission. N Engl J Med 1986: 315: 993–997.CrossRefGoogle ScholarPubMed
25.Waserman, J, Lai, S, Gauthier, S.Gilles de la Tourette’s syndrome in monozygotic twins. J Neurol Neurosurg Psychiatry 1983; 46: 75–77.CrossRefGoogle ScholarPubMed
26.Price, A, Kidd, K.Cohen, D, et al. A twin study of Tourette syndrome. Arch Gen Psychiatry 1985; 42: 815–820.CrossRefGoogle ScholarPubMed
27.Comings, DE, Comings, BG, Dietz, G, et al. Evidence the Tourette syndrome gene is at 18q:22.1. 7th International Congress of Human genetics. Berlin, 1986 abstract 11: 620.Google Scholar
28.Jankovic, J.Recent advances in the management of tics. Clin Neuro-pharmacol 1986 (Suppl 2); S100–S110.Google ScholarPubMed
29.Erenberg, G.Gruse, RP.Rothner, DA.Gilles de laTourette’s syndrome.Effects of stimulant drugs. Neurology 1985:35: 1346–1348.CrossRefGoogle Scholar
30.Spitz, MC, Jankovic, J.Killian, JM.Familial tic disorder, parkinsonism. motor neuron disease, and acanthocytosis - a new syndrome. Neurology 1985; 35: 366–377.CrossRefGoogle ScholarPubMed
31.Koslow, SH, Cross, CK.Cerebrospinal fluid monoamine metabo-lites in Tourette syndrome and their neuroendocrine implications. In: Gilles de la Tourette syndrome. Friedhoff, AJ.Chase, TN. eds. Adv Neurol 1982: 35: 185–197.Google Scholar
32.Cohen, DJ, Shaywitz, BA, Young, JG.et al. Central biogenic aminemetabolism in children with the syndrome of chronic multiple tics of Gilles de la Tourette: Norepinephrine, serotonin and dopamine. J Am Acad Child Psychiatry 1979; 18: 320–341.CrossRefGoogle ScholarPubMed
33.Butler, IJ.Tourette’s syndrome. Some new concepts. In: Move-ment Disorders. Jankovic, J. ed. Neurol Clin 1984; 2: 571–580.CrossRefGoogle ScholarPubMed
34.Singer, HS, Wong, DF.Tiemeyer, M, et al. Pathophysiology of Tourette syndrome. A PET and postmortem analysis.Ann Neurol 1985; 18: 446.Google Scholar
35.Haber, SN.Kowell, NW, Vonsattel, JP.et al. Lackofdynorphin. but no enkephalin or substance P. immunoreactivity in the dorsal globus pallidus in Gilles de la Tourette’s syndrome. J Neurol Sci 1986:75: 225–241.CrossRefGoogle ScholarPubMed
36.Seignot, MJN.A case of the syndrome of tics of Gilles de la Tourette controlled by R1625. Am Med Psychol 1961:119:578–579.Google Scholar
37.Shapiro, AK, Shapiro, E.The treatment and etiology of tics and Tourette syndrome. Compr Psychiatry 1981; 22: 193–205.CrossRefGoogle ScholarPubMed
38.Mizrahi, EM, Holtzman, D, Tharp, B.Haloperidol-induced tardive dyskinesia in a child with Gilles de la Tourette’s syndrome. Arch Neurol 1980: 37: 780.CrossRefGoogle Scholar
39.Golden, GS.Tardive dyskinesia in Tourette’s syndrome. Ann Neurol 1984: 16: 390.Google Scholar
40.Jankovic, J.Cranial-cervical dyskinesias. In: Appel, SH. ed. Cur-rent Neurology. Year Book Medical Publishers. Chicago, 1986, Vol 6. pp 153–176.Google Scholar
41.Goetz, CG, Tanner, CM, Klawans, HL.Fluphenazine and multifocaltic disorders. Arch Neurol 1984:41: 271–272.CrossRefGoogle ScholarPubMed
42.Borison, RL.Ang, L, Change, S.et al. New pharmacological approaches in the treatment of Tourette syndrome. In: Gilles de la Tourette Syndrome. (Eds.) Friedhoff, AJ.Chase, TN.Adv Neurol New York, Raven Press 1982; Vol 35, pp 377–382.Google Scholar
43.Shapiro, AK, Shapiro, E.Controlled study of pimozide vs. placebo in Tourette’s syndrome. J Am Acad Child Psychiatry 1984; 23: 161–173.CrossRefGoogle ScholarPubMed
44.Regeur, L, Pakkenberg, B, Fog, G, Pakkenberg, H.Clinical features and long-term treatment with pimozide in 65 patients with Gilles de laTourette’s syndrome. J Neurol Neurosurg Psychiatry 1986: 49: 791–795.CrossRefGoogle Scholar
45.Jankovic, J.Glaze, DG.Frost, JD.Effect of tetrabenazine on tics and sleep of Gilles de la Tourette’s syndrome. Neurology 1984: 34: 688–692.CrossRefGoogle ScholarPubMed
46.Svensson, TH, Bunney, BS, Aghajanian, GK.Inhibition of both noradrenergic and serotonergic neurons in brain by the alpha-adrenergic agonist clonidine. Brain Res 1975: 92: 291–306.CrossRefGoogle ScholarPubMed
47.Young, JG, Cohen, DJ, Hattox, SE.Plasma free MHPG and neuroen-docrine responses to challenge doses of clonidine in Tourette’s syndrome: Preliminary report. Life Sci 1981: 29: 1467–1475.CrossRefGoogle Scholar
48.Leckman, JF.Detlor, J, Harcherick, DF, et al. Short and long termtreatment of Tourette’s syndrome with clonidine: A clinical perspective. Neurology 1985: 35: 343–351.CrossRefGoogle Scholar
49.Gonce, M, Barbeau, A.Seven cases of Gilles de la Tourette’s syndrome: Partial relief with clonazepam: A pilot study. Can J Neurol Sci 1977; 4: 279–283.CrossRefGoogle ScholarPubMed
50.Caine, ED.Gilles de la Tourette’s syndrome. A review of clinical and research studies and consideration of future directions for investigation. Arch Neurol 1985: 42: 393–397.CrossRefGoogle ScholarPubMed
51.Mansdorf, I. Assertiveness training in the treatment of a child’stics. J Behav Ther Exp Psychiatry 1986: 17: 29–32.CrossRefGoogle Scholar